Covered recipient · General Payments record
RIVKAH HOROWITZ
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$5,351.60
- Reported across 221 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,622.66 | 59 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $150.88 | 7 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $148.67 | 3 |
| SANOFI-AVENTIS U.S. LLC | $139.42 | 6 |
| Pharming Healthcare, Inc. | $113.40 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $107.08 | 1 |
| GENZYME CORPORATION | $104.92 | 1 |
| Radius Health, Inc. | $88.27 | 4 |
| Amneal Pharmaceuticals LLC | $65.43 | 3 |
| Alexion Pharmaceuticals, Inc. | $63.58 | 3 |
| Lilly USA, LLC | $58.15 | 2 |
| Almatica Pharma Inc. | $50.78 | 2 |
| Averitas Pharma Inc. | $50.39 | 2 |
| BETA BIONICS, INC. | $48.32 | 2 |
| Corcept Therapeutics | $48.03 | 2 |
| Novo Nordisk AS | $47.42 | 3 |
| CeQur Corporation | $44.18 | 1 |
| Amgen Inc. | $43.41 | 2 |
| Tandem Diabetes Care, Inc. | $42.29 | 3 |
| Abbott Laboratories | $28.80 | 2 |
| Ascendis Pharma Inc | $25.91 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.85 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.07 | 1 |
| Nevro Corp. | $20.14 | 1 |
| Neurocrine BioSciences, Inc. | $20.14 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $18.01 | 1 |
| Acella Pharmaceuticals, LLC | $16.96 | 1 |
| Regeneron Healthcare Solutions, Inc. | $16.75 | 1 |
| Medtronic, Inc. | $14.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (59)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.